Ireland
--:--IST
Recruiting Not applicable

Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

NCT07372157 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-06-15
Last updated
2026-01-28

Condition(s) studied

Overweight and Obesity

Investigational drug(s) / intervention(s)

Aerobic and strength trainingNeuromuscular balance exercises

Aerobic and strength training: The aerobic and strength training program consists of supervised exercise sessions performed three days per week for eight weeks. Aerobic exercises are conducted at a moderate intensity, and strength training targets major muscle groups using body weight and resistance-based exercises. Each session is structured to include warm-up, main exercise components, and cool-down phases.

Neuromuscular balance exercises: Neuromuscular balance exercises are added to the standard exercise program and are designed to improve postural control and balance. The exercises include progressive static and dynamic balance tasks and are performed three times per week for eight weeks under supervision.

Study summary

This randomized controlled study aims to evaluate the effects of adding neuromuscular balance exercises to exercise programs on functional capacity, balance, and physical fitness in individuals with obesity. Forty participants will be randomly assigned to either a control group receiving aerobic and strength training exercises or an intervention group receiving aerobic and strength training combined with neuromuscular balance exercises. Both exercise programs will be conducted three times per week for eight weeks. Functional capacity, balance, and physical fitness outcomes will be assessed at baseline and after the intervention period. The findings are expected to contribute to the integration of balance-focused exercises into rehabilitation programs for individuals with obesity.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Volunteering to participate in the study * Having a BMI of 25-35 kg/m2 * Not having undergone any surgical operation in the last 6 months Exclusion Criteria: * Any musculoskeletal disorder or systemic disease that would prevent exercise * Balance problems due to any disease that could prevent exercise * Psychiatric or neurological disease affecting cooperation and cognitive functions * Acute pain for any reason * Chest pain * History of myocardial infarction within the last year * Congestive heart failure * Patient's inability to adhere to treatment

Primary outcome measure(s)

  • Dynamic Balance Performance (Four Step Square Test) — Baseline, at the 4th weeks and at the end of 8 weeks
    Dynamic balance will be assessed using the Four Step Square Test, which measures the time (in seconds) required to complete a multidirectional stepping sequence.
  • Postural Control (Functional Reach Test) — Baseline, Week 4, and Week 8
    Postural control will be evaluated using the Functional Reach Test, which measures the maximal forward reach distance (in centimeters) while maintaining a fixed base of support.
  • Walking Endurance (2-Minute Walk Test) — Baseline, at the 4th weeks and at the end of 8 weeks
    Walking endurance will be assessed using the 2-Minute Walk Test, which measures the total distance walked in meters over a two-minute period.
  • Lower Extremity Functional Strength (30-Second Chair Stand Test) — Baseline, Week 4, and Week 8
    Lower extremity functional strength will be evaluated using the 30-Second Chair Stand Test, which measures the number of full stands completed within 30 seconds.

Trial sites (1)

FacilityCityRegionStatus
Fatih Sultan Mehmet Training and Research Hospital, Diabetes and Obesity Treatment Center Istanbul Istanbul Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07372157 on ClinicalTrials.gov ↗ ← All trials in Turkey